# Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”

**Authors:** Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan

PMC · DOI: 10.2196/58273 · 2024-05-01

## Full-text entities

- **Diseases:** Thyroid Hyperplasia (MESH:D006965), Neoplasm (MESH:D009369)

---
Source: https://tomesphere.com/paper/PMC11090022